# A Study in Subjects With Perennial Allergic Rhinitis

> **NCT00210015** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 630 (—)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** INS37217 Nasal Spray

## Key facts

- **NCT ID:** NCT00210015
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 630 (—)
- **Last updated:** 2016-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210015, "A Study in Subjects With Perennial Allergic Rhinitis". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00210015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*